Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell

Immunology Letters

Volumn 108, Issue 1, 2007, Pages 78-87

  Zhao, Yong ^a   Huang, Zhihua ^a   Qi, Meirigeng ^a   Lazzarini, Ping ^a   Mazzone, Theodore ^a  

^a Section of Endocrinology Diabetes and Metabolism   (United States)

Author keywords

Nitric oxide; PD L1; Stem cell; T lymphocyte; Umbilical cord blood

Indexed keywords

DEATH RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; N(G) NITROARGININE; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHYTOHEMAGGLUTININ; PROGRAMMED DEATH RECEPTOR 1 LIGAND 1; PROSTAGLANDIN E2; STAT5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; STEM CELL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD STEM CELL;

CD4-CD8 RATIO; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; FEMALE; FETAL BLOOD; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; PREGNANCY; STEM CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 33845599940     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.10.007     Document Type: Article

References (46)

1. Vats A., Bielby R.C., Tolley N.S., Nerem R., and Polak J.M. Stem cells. Lancet 366 (2005) 592-602
2. Hussain M.A., and Theise N.D. Stem-cell therapy for diabetes mellitus. Lancet 364 (2004) 203-205
3. Rice C.M., and Scolding N.J. Adult stem cells-reprogramming neurological repair?. Lancet 364 (2004) 193-199
4. Hoffman L.M., and Carpenter M.K. Characterization and culture of human embryonic stem cells. Nat Biotechnol 23 (2005) 699-708
5. Wilan K.H., Scott C.T., and Herrera S. Chasing a cellular fountain of youth. Nat Biotechnol 23 (2005) 807-815
6. Bradley J.A., Bolton E.M., and Pedersen R.A. Stem cell medicine encounters the immune system. Nat Rev Immunol 2 (2002) 859-871
7. Drukker M. Characterisation of MHC protein expression in human embryonic stem cells. Proc Natl Acad Sci 99 (2002) 9864-9869
8. Bonde J., Hess D.A., and Nolta J.A. Recent advances in hematopoietic stem cell biology. Curr Opin Hematol 11 (2004) 392-398
9. Melton D.A., Daley G.Q., and Jennings C.G. Altered nuclear transfer in stem-cell research-a flawed proposal. N Engl J Med 351 (2004) 2791-2792
10. Draper J.S., Pigott C., Thomson J.A., and Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200 (2002) 249-258
11. Roche E., Reig J.A., Campos A., Paredes B., Isaac J.R., Lim S., et al. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes. Transpl Immunol 15 (2005) 113-129
12. Evans M. Ethical sourcing of human embryonic stem cells-rational solutions?. Nat Rev Mol Cell Biol 6 (2005) 663-667
13. Zhao Y., Glesne D., and Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100 (2003) 2426-2431
14. Zhao Y., Wang H., and Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312 (2006) 2454-2464
15. Zhao Y., and Mazzone T. Human umbilical cord blood-derived f-macrophages retain pluripotentiality after thrombopoietin expansion. Exp Cell Res 310 (2005) 311-318
16. Ballen K.K. New trends in umbilical cord blood transplantation. Blood 105 (2005) 3786-3792
17. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94 (1994) 2036-2044
18. Zhang H., Conrad D.M., Butler J.J., Zhao C., Blay J., and Hoskin D.W. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3′,5′-monophosphate and phosphatases. J Immunol 173 (2004) 932-944
19. Campbell J.D., Cook G., Robertson S.E., Fraser A., Boyd K.S., Gracie J.A., et al. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. J Immunol 167 (2001) 553-561
20. Sarraj B., Ludanyi K., Glant T.T., Finnegan A., and Mikecz K. Expression of CD44 and l-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol 177 (2006) 1932-1940
21. Dianzani U., and Malavasi F. Lymphocyte adhesion to endothelium. Crit Rev Immunol 15 (1995) 167-200
22. Sancho D., Gomez M., and Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26 (2005) 136-140
23. + regulatory T cells and their therapeutic potential. Annu Rev Med 57 (2006) 381-402
24. Choileain N.N., and Redmond H.P. Regulatory T-cells and autoimmunity. J Surg Res 130 (2006) 124-135
25. Paust S., and Cantor H. Regulatory T cells and autoimmune disease. Immunol Rev 204 (2005) 195-207
26. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35 (2005) 1482-1490
27. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 203 (2006) 883-895
28. Zha Y., Blank C., and Gajewski T.F. Negative regulation of T-cell function by PD-1. Crit Rev Immunol 24 (2004) 229-237
29. Tilley S.L., Coffman T.M., and Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108 (2001) 15-23
30. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
31. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 312 (2006) 2169-2179
32. Mahidhara R.S., Hoffman R.A., Huang S., Wolf-Johnston A., Vodovotz Y., Simmons R.L., et al. Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74 (2003) 403-411
33. Saudemont A., Jouy N., Hetuin D., and Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105 (2005) 2428-2435
34. Ziegler S.F., Ramsdell F., and Alderson M.R. The activation antigen CD69. Stem Cells 12 (1994) 456-465
35. Testi R., D'Ambrosio D., De Maria R., and Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15 (1994) 479-483
36. + T cells in autoimmunity. Curr Opin Immunol 17 (2005) 624-631
37. + T cells in NOD mice. Immunol Rev 204 (2005) 250-263
38. + T cells in multiple sclerosis: a new target for therapy?. Brain 128 (2005) 1747-1763
39. Uccelli A., Moretta L., and Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36 (2006) 2566-2573
40. +-derived and monocyte-derived dendritic cells. J Immunol 177 (2006) 2080-2087
41. Inoue S., Popp F.C., Koehl G.E., Piso P., Schlitt H.J., Geissler E.K., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81 (2006) 1589-1595
42. Sudres M., Norol F., Trenado A., Gregoire S., Charlotte F., Levacher B., et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176 (2006) 7761-7767
43. Nauta A.J., Westerhuis G., Kruisselbrink A.B., Lurvink E.G., Willemze R., and Fibbe W.E. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108 (2006) 2114-2120
44. Powell T.J., Jenkins C.D., Hattori R., and MacPherson G.G. Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation. Immunology 109 (2003) 197-208
45. + myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-gamma- and nitric oxide-dependent mechanism. J Immunol 171 (2003) 726-732
46. Kosonen O., Kankaanranta H., Lahde M., Vuorinen P., Ylitalo P., and Moilanen E. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism. J Pharmacol Exp Ther 286 (1998) 215-220